NCT05815329 · RECRUITING
MASCoD - Multidimensional Assessment of Subjective Cognitive Decline
This trial is testing a new screening questionnaire called MASCoD, designed to detect and track subjective cognitive decline — the stage where someone feels their memory or thinking has slipped, but standard tests come back normal. Researchers want to see if MASCoD scores predict who will develop more serious cognitive decline over time. It also tests whether a tablet-based cognitive training program helps, and whether MASCoD can measure that improvement. This is a Phase NA study — essentially a validation and feasibility study, not a drug trial.
You may qualify if
- reported subjective cognitive decline without any other cognitive or neurological issue,
- Italian education,
- adult (> 55 years old),
- understanding of research aims,
- signed informed consent,
- participation on a voluntary and non-payied bases.
You're excluded if
- serious clinical conditions (e.g. severe cardiac and respiratory problems, neoplasia)
- prior diagnosis of psychiatric disorders according to DSM-5,
- prior diagnosis of cognitive decline,
- relevant visuo-perceptive or hearing deficits,
- illiteracy or relapse in illiteracy,
- refusal to partake in the research.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-05-08